Josh Gao, CEO of robot-data supplier Mecka AI, says labs train on about a million hours of human data, tens of thousands of gripper hours and a few teleop hours. He argues scaling that alone won't yield a robot that learns any task by watching.
Alexander Wissner-Gross forecast that virtual-cell AI will propose small-molecule cures for the top 5,000 diseases within two to three years. He said regulatory approval would be a harder, policy-dependent question.
Hosts on Moonshots welcomed FutureHouse and Edison Scientific's 12 lab-testable "Millennium Problems for Biology." Peter Diamandis said age reversal, left off the list, is measurable in days, though his XPRIZE Healthspan uses year-long trials.
GenBio's AIDO Cell simulates a human cell that remembers successive edits and drugs. For now it helps prioritize experiments in two cell lines; lab validation of its novel predictions is underway. A Moonshots panelist called it the end of medicine.
Brian Greene argues AI could make Newton-scale discoveries, expecting it to excel at exploring options and linking fields while humans, for now, lead in inventing new frameworks. He sees collaboration reshaping physicists' role.
May we use a browser ID to count visits, article reading, return visits and how readers found us? The statistics stay on our server. We also count daily page totals without analytics cookies or visitor IDs.